The UAE research and development (“R&D”) tax credit regime, introduced under Cabinet Decision No. 215 of 2025 and Ministerial Decision No. 24 of 2026, applies to tax periods beginning on or after 1 January 2026. As part of the UAE corporate tax framework, the regime provides a credit against tax for qualifying R&D expenditure, subject to specific conditions. Access to the credit depends not simply on whether the R&D activities were undertaken or the level of expenditure incurred, but on how they are carried out and substantiated.
The introduction of the regime reflects the UAE’s broader policy focus on innovation, technology development and the growth of a knowledge-based economy. The credit is intended to incentivise substantive R&D activity within the UAE, while aligning tax outcomes with where value is created.
This article outlines how the credit is obtained and claimed, what must be in place during the relevant tax period, and the key structuring and risk considerations that determine whether claims are sustainable in practice.
Overview of the R&D Tax Credit
The regime provides a tax credit on qualifying R&D expenditure.
The current rates are:
- 15% on the first AED 1 million of qualifying R&D expenditure, where at least 2 R&D staff are maintained on average
- 35% on qualifying expenditure above AED 1 million up to AED 2 million, where at least 6 R&D staff are maintained on average
- 50% on qualifying expenditure above AED 2 million up to AED 5 million, where at least 14 R&D staff are maintained on average
The R&D credit is available to UAE entities, including free zone persons, and to foreign entities operating through a UAE permanent establishment that undertake Qualifying R&D activities and are subject to UAE corporate tax or domestic minimum top-up tax (“DMTT”) for the relevant period.
Qualifying Free Zone Persons benefitting from the 0% rate and entities that have elected to apply small business relief do not qualify.
The credit is offset against UAE corporate tax and, where applicable, DMTT. Unutilised credits may be carried forward and, in certain cases, transferred within qualifying group structures, subject to anti- abuse and claw-back provisions.
The credit does not give rise to a cash refund. As a result, the benefit of the credit will depend on the claimant’s tax position and the ability to utilise it within the relevant group structure.
The credit also affects DMTT calculations and is relevant for multinational groups within the scope of Pillar Two.
Claiming the R&D Credit
The R&D tax credit is claimed through the relevant UAE corporate tax return, or Top-up Tax return where applicable, for the tax period in which the qualifying expenditure is incurred. The credit is not automatic. It must be assessed, calculated and supported by appropriate documentation.
A key feature of the regime is the requirement for pre-approval of R&D projects. Businesses must obtain approval from the Emirates Research and Development Council for projects intended to qualify, in accordance with prescribed procedures and timelines. Obtaining pre-approval is a condition to claiming the credit.
A claim must be accompanied by supporting documentation, including:
- proof of pre-approval of the relevant R&D project;
- supporting financial information, including audited accounts where applicable;
- a breakdown of qualifying expenditure; and
- a declaration confirming compliance with the conditions of the regime.
Additional information or documentation may be required to substantiate that the activities meet the qualifying criteria.
The burden of demonstrating eligibility rests with the taxpayer. Unsupported or late claims carry a significant risk of rejection.
Qualifying R&D Activities
To qualify, R&D activities must involve technical uncertainty and seek to achieve an advance in science or technology. Activities must be carried out as part of an organised R&D project in line with internationally recognised principles. Activities in the social sciences, humanities and the arts are excluded. Where activities are undertaken partly within and partly outside the UAE, only the portion carried out in the UAE may qualify.
The key test is whether the activity addresses genuine technical uncertainty and seeks to achieve an advance beyond existing knowledge or capability. This requires a systematic approach to resolving that uncertainty and evidence of how the work progresses beyond existing solutions. Activities described as development, enhancement or engineering will not qualify unless they meet this threshold, regardless of how they are labelled.
Although the qualifying criteria are not identical to patentability requirements, there is often overlap between qualifying R&D and work that generates protectable intangible assets, including inventions, software, know-how and other forms of intellectual property, and the criteria should be considered alongside patentability and disclosure requirements. This has implications for how projects are structured and how resulting outputs are managed, particularly where disclosures to collaborators, subcontractors or other third parties are involved.
Not all technical, engineering, software development or product improvement work will qualify. The distinction between qualifying R&D and routine development or implementation work is a key area of scrutiny. Incorrect classification of activities, particularly where work is framed broadly as “development”, may result in claims being challenged or denied.
Particular care is required in areas such as software development, product enhancement and engineering activities, where the boundary between qualifying R&D and routine or commercially driven work is often unclear. Overly broad classification of such activities will likely be a common source of challenge, particularly where there is limited evidence of technical uncertainty or advancement.
Qualifying R&D Expenditure
Qualifying R&D expenditure may include staff costs, consumables, subcontracting fees, cost contribution arrangements, certain capitalised costs relating to internally generated intangibles, and licence fees and other non capital costs related to intangible assets used in R&D activities.
Qualifying expenditure is subject to specific conditions. It must be incurred wholly and exclusively for qualifying R&D activities, or apportioned where incurred for mixed purposes. It must constitute deductible expenditure for corporate tax purposes. It must not be funded directly or indirectly by grants. It must not benefit from other tax incentives, credits or exemptions. A minimum threshold of AED 500,000 applies per R&D project in the relevant period.
The regime places significant emphasis on the ability to demonstrate a clear and supportable link between the expenditure, the qualifying activity and the entity claiming the credit. This is not a formality. It is a substantive requirement that determines whether costs qualify in practice.
The inclusion of licence fees highlights the link between the regime and technology and IP strategy.
Qualifying costs may arise where patents, know how, software, databases or other licensed IP are used directly in R&D projects. However, the treatment of these costs depends on how the arrangements are structured. Intra group recharges, shared development models and cost contribution arrangements may give rise to challenges where there is a disconnect between the entity incurring the cost and the entity entitled to benefit from the resulting R&D outcomes.
Training costs for R&D staff may qualify where they are directly related to qualifying activities. This includes training aimed at enabling teams to undertake R&D in a manner that meets the required criteria. Demonstrating that such costs are directly attributable to qualifying activities will be important and is likely to be subject to scrutiny.
The key issue is not whether expenditure has been incurred, but whether it can be shown to relate directly to qualifying R&D activities. Costs associated with broader innovation, product development or commercial activity will not qualify unless they meet the technical criteria and are properly evidenced. This requires alignment between technical activities, cost allocation and the entity claiming the credit. Intra group cost allocations and recharge mechanisms are therefore likely to attract particular scrutiny, particularly where the economic benefit of the R&D outcomes is realised by a different entity.
Timing and Process
Eligibility under the regime is determined by reference to how R&D activities are actually undertaken during the relevant tax period, not how they are described at the point of filing. It cannot be established retrospectively.
The requirement for project pre-approval, together with the need for detailed supporting documentation, means that key elements of eligibility must be addressed at the outset of a project and maintained throughout its lifecycle. This extends beyond initial approval and includes how activities evolve, how technical decisions are made, and how those decisions are recorded and supported over time.
In practical terms, this requires:
- early identification and classification of R&D projects
- timely submission of projects for pre-approval
- contemporaneous documentation of technical uncertainty, methodology, iterations and outcomes, including unsuccessful approaches where relevant
- structured tracking of qualifying expenditure, including staff time and consumables
- alignment of contractual arrangements with the intended allocation of functions, risks and economic benefits.
The regime imposes record-keeping obligations, including retention of documentation for a period of seven years. Documentation must be sufficient to demonstrate both the technical and financial basis of the claim, and to establish a clear link between them.
Attempting to reconstruct qualifying R&D positions at year end, without contemporaneous evidence or appropriate project approval, carries a high risk of challenge or denial. Similarly, restructuring arrangements mid-project to align with the regime is unlikely to be effective where the underlying activities and risk allocation do not support the intended outcome.
R&D, Innovation and IP Structuring Considerations
Entitlement to the credit requires that the claimant bears the financial burden of the R&D and is beneficially entitled to the returns derived from exploiting the resulting intangibles or other R&D outcomes. As a result, the structuring of R&D arrangements, including contractual allocation of functions, risks and rights to IP, is central to determining entitlement to the credit.
Particular attention should be given to how intellectual property ownership of resulting inventions and developments is determined in practice, especially in the context of employee, consultant, subcontracting and joint development arrangements, and to the distinction between background and foreground IP. These elements should be clearly defined and consistently implemented, including how rights in pre-existing IP and newly developed IP are allocated, as they are relevant not only for IP protection and commercialisation, but also in determining entitlement to the economic return from the R&D activities. The timing of IP protection should also be considered, as premature disclosure of R&D outputs before appropriate protection is secured may affect the ability to obtain IP protection including patents, trade secrets and confidential know-how.
The allocation of R&D functions, risks and assets within a group, and the structuring of collaboration and subcontracting arrangements, will directly impact eligibility. This includes how R&D activities are funded, how costs are allocated, and whether the entity incurring those costs is appropriately positioned to benefit from the resulting outcomes and related IP rights. The entity claiming the credit should be able to demonstrate that it exercises control over the R&D activities and bears the associated risks and benefit from the resulting achievements in substance, not merely as a matter of contractual form. Where these elements are not aligned, expenditure may not qualify or credits may be denied or clawed back.
For example, where R&D activities are carried out in the UAE by a service entity but the resulting IP is contractually owned by another group entity, the UAE entity may incur qualifying expenditure without being entitled to the economic return from the R&D outcomes. In such cases, entitlement to the credit may be restricted or subject to challenge, particularly where the contractual allocation of rights does not reflect the underlying conduct of the activities.
Staffing arrangements are also relevant in determining whether R&D staff costs qualify and whether ownership of resulting innovations is appropriately addressed through employment, consultancy, secondment or invention assignment arrangements. These arrangements should clearly support the intended allocation of ownership and economic return, and be consistent with the broader structuring of the R&D activities.
Misalignment between legal ownership, economic ownership and the conduct of R&D activities is a key risk area. The regime includes mechanisms for adjustment and clawback where conditions are not met on an ongoing basis, particularly where there is a disconnect between the entity incurring R&D costs and the entity entitled to exploit the resulting IP, or where group structures are modified after the fact. These elements should be established at the outset of the R&D activities, as arrangements implemented or revised retrospectively are unlikely to be effective in supporting entitlement to the credit.
Planning and Implementation
Businesses should approach the R&D tax credit as a forward-looking planning and operational exercise, rather than a year-end tax adjustment. This requires R&D, innovation and IP considerations to be addressed at an early stage, with activities, arrangements and ownership structured consistently with the requirements of the regime from the outset.
This involves ensuring that R&D activities are clearly identified and assessed against the qualifying criteria, that contractual arrangements and IP ownership reflect the intended allocation of functions, risks and economic returns, and that internal processes support the contemporaneous tracking of both technical activities and associated costs. This includes the implementation of systems that enable real-time identification and monitoring of qualifying activities, rather than reliance on retrospective analysis or reclassification, and the capture of inventions and other IP arising from R&D activities as they are developed.
Effective implementation also requires coordination between technical, finance and legal teams, and the establishment of governance processes that ensure consistency between how activities are undertaken, how they are recorded, and how they are ultimately presented in a claim. Weaknesses in alignment, tracking or documentation may undermine otherwise valid claims.
Key focus areas include:
- early planning, structuring, identification and classification of R&D activities
- alignment of contractual arrangements and IP ownership with underlying activities
- implementation of systems for documentation and real-time tracking of activities and costs
- coordination between technical, finance and legal function
- establishment of governance and review processes
- consideration of IP protection strategy including the timing of patent filings and management of confidential information prior to disclosure
Failure to address these areas may result in claims being challenged, denied or adjusted on review.
Potential Challenges and Risk Areas
In applying the regime, a number of areas where challenges can be anticipated, particularly where there is a disconnect between how R&D activities are undertaken in practice and how they are characterised in a claim.
Key risk areas include:
- classification of software development and product improvement activities as qualifying R&D where technical uncertainty is not clearly evidenced
- inclusion of costs that do not meet the definition of qualifying expenditure or cannot be directly linked to qualifying activities
- intra-group and subcontracting arrangements where the entity performing the R&D differs from the entity claiming the credit, or where economic return is not aligned
- R&D collaboration arrangements where the entity claiming the credit does not benefit from the resulting developments or IP ownership
- projects involving both UAE and non-UAE activities, requiring careful allocation of qualifying expenditure
- retrospective adjustments, including reclassification of activities or restructuring of arrangements after the fact
- inconsistencies between technical documentation and financial claims, or insufficient evidence to support the technical basis of the activities
These areas are likely to be a focus in any review or audit process. Weaknesses in classification, alignment or substantiation may result in claims being reduced, denied or subject to adjustment or clawback.
Key Takeaways
The UAE R&D tax credit regime presents a meaningful opportunity for businesses investing in innovation. However, access to the credit depends on more than the existence of qualifying R&D activity.
Availability of the credit ultimately depends on whether R&D activities are undertaken, structured and supported in line with the requirements of the regime. This includes the alignment of activities, expenditure and IP ownership, the implementation of appropriate contractual and governance arrangements, and the ability to demonstrate this through contemporaneous documentation.
Eligibility is established by reference to how activities are conducted over the relevant tax period, not through retrospective analysis or recharacterisation. Planning, structuring and documentation must therefore be addressed at the outset and maintained throughout the lifecycle of the R&D activities.
In practice, the most significant risks arise not from the absence of R&D activity, but from misalignment between technical activity, financial treatment and legal arrangements. Businesses that address these requirements early, and embed them into the design and execution of their R&D activities, are more likely to secure and sustain the benefit of the credit, while those that rely on retrospective adjustments face a significantly higher risk of challenge or denial.
How They Support Businesses
The UAE R&D tax credit regime requires businesses to bring together technical, financial and legal considerations. This requires coordination across tax, IP, R&D and innovation disciplines.
Our combined Tax and 3IP team can support businesses across the lifecycle of a claim, from initial assessment through to claim preparation and audit defence.
Our support includes:
- assessing whether activities and expenditure meet the conditions of the regime
- identifying qualifying projects and addressing pre-approval requirements at the appropriate stage
- reviewing existing arrangements to identify gaps or areas of risk
- aligning R&D activities, IP ownership and contractual arrangements with the intended allocation of functions, risks and economic returns
- designing documentation, governance and cost tracking processes
- preparing claims and supporting materials that reflect the underlying technical and financial position
- providing training and workshops on the application of the regime, including practical guidance on planning, structuring and governance of R&D activities and associated IP rights
- responding to queries, reviews and audits, including where arrangements require refinement
For more information, please contact the key contacts.
Key Contacts
Ahmad Saleh, Partner, Head of Innovation, Patents & Industrial Property, ah.saleh@tamimi.com
Shiraz Khan, Partner, Head of Taxation, s.khan@tamimi.com